PHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2004
| PHARMANIAGA BERHAD |
|
Quarterly report for the financial period ended | 31/12/2004 |
| Quarter | 4 |
| Financial Year End | 31/12/2004 |
| The figures | have been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2004 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2004 | 31/12/2003 | 31/12/2004 | 31/12/2003 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 200,777 | 166,617 | 799,991 | 632,604 |
| 2 | Profit/(loss) before tax | 22,264 | 18,664 | 81,778 | 66,841 |
| 3 | Profit/(loss) after tax and minority interest | 13,368 | 9,495 | 50,835 | 40,756 |
| 4 | Net profit/(loss) for the period | 13,368 | 9,495 | 50,835 | 40,756 |
| 5 | Basic earnings/(loss) per share (sen) | 13.12 | 9.47 | 50.18 | 40.70 |
| 6 | Dividend per share (sen) | 10.50 | 8.50 | 15.00 | 12.00 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 2.6000 | 2.2200 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
| Remarks : |
| For the current financial year ended 31 December 2004, the Board of Directors recommends a final tax exempt dividend of 10.5 sen per share. The dates of entitlement and payment will be announced at a later date. |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 23 Feb 2005 |
| Category | Financial Results |
| Reference No | CC-050223-42602 |